Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease

By rosaguerrero • June 26, 2022

Koury MJ, Agarwal R, Chertow GM, Eckardt KU, Fishbane S, Ganz T, Haase VH, Hanudel MR, Parfrey PS, Pergola PE, Roy-Chaudhury P, Tumlin JA, Anders R, Farag YMK, Luo W, Minga T, Solinsky C, Vargo DL, Winkelmayer WC. Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease. Am J Hematol. 2022 Jun 25. doi: 10.1002/ajh.26644. Epub ahead of print. PMID: 35751858.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Related Posts

Disparities in Early Lecanemab Uptake Among US Medicare Beneficiaries

Zhou FF, Essien UR, Souza JM, Sarkisian CA, Damberg CL, Landon BE, Mafi JN. Disparities in Early Lecanemab Uptake Among US Medicare Beneficiaries. JAMA Netw[...]

Digital Health Technology Use Among Spanish Speakers in the US: A Scoping Review

Higashi RT, Thakur B, Repasky EC, Casillas A, Steitz BD, Hogan TP, Lehmann CU, Peterson ED, Navar AM, Turer RW. Digital Health Technology Use Among[...]

Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical Trial

Nikitas J, Ballas LK, Romero T, Lynch C, Ma TM, Valle LF, Sachdeva A, Chong N, Basehart V, Franco A, Reiter R, Saigal C, Chamie[...]